Literature DB >> 17687107

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia.

Gabrielle S Sellick1, Lynn R Goldin, Ruth W Wild, Susan L Slager, Laura Ressenti, Sara S Strom, Martin J S Dyer, Francesca R Mauro, Gerald E Marti, Stephen Fuller, Matthew Lyttelton, Thomas J Kipps, Michael J Keating, Timothy G Call, Daniel Catovsky, Neil Caporaso, Richard S Houlston.   

Abstract

Chronic lymphocytic leukemia (CLL) and other B-cell lymphoproliferative disorders display familial aggregation. To identify a susceptibility gene for CLL, we assembled families from the major European (ICLLC) and American (GEC) consortia to conduct a genome-wide linkage analysis of 101 new CLL pedigrees using a high-density single nucleotide polymorphism (SNP) array and combined the results with data from our previously reported analysis of 105 families. Here, we report on the combined analysis of the 206 families. Multipoint linkage analyses were undertaken using both nonparametric (model-free) and parametric (model-based) methods. After the removal of high linkage disequilibrium SNPs, we obtained a maximum nonparametric linkage (NPL) score of 3.02 (P = .001) on chromosome 2q21.2. The same genomic position also yielded the highest multipoint heterogeneity LOD (HLOD) score under a common recessive model of disease susceptibility (HLOD = 3.11; P = 7.7 x 10(-5)), which was significant at the genome-wide level. In addition, 2 other chromosomal positions, 6p22.1 (corresponding to the major histocompatibility locus) and 18q21.1, displayed HLOD scores higher than 2.1 (P < .002). None of the regions coincided with areas of common chromosomal abnormalities frequently observed in CLL. These findings provide direct evidence for Mendelian predisposition to CLL and evidence for the location of disease loci.

Entities:  

Mesh:

Year:  2007        PMID: 17687107      PMCID: PMC2200912          DOI: 10.1182/blood-2007-05-091561

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

Review 1.  Cytogenetic abnormalities in chronic lymphocytic leukemia.

Authors:  I N Karnolsky
Journal:  Folia Med (Plovdiv)       Date:  2000

2.  CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not.

Authors:  Naoko Ishibe; Maher Albitar; Iman B Jilani; Lynn R Goldin; Gerald E Marti; Neil E Caporaso
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

3.  Guidelines for genotyping in genomewide linkage studies: single-nucleotide-polymorphism maps versus microsatellite maps.

Authors:  David M Evans; Lon R Cardon
Journal:  Am J Hum Genet       Date:  2004-08-13       Impact factor: 11.025

Review 4.  Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells.

Authors:  Jan A Burger; Thomas J Kipps
Journal:  Leuk Lymphoma       Date:  2002-03

5.  Association of chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients.

Authors:  H K Machulla; L P Müller; A Schaaf; G Kujat; U Schönermarck; J Langner
Journal:  Int J Cancer       Date:  2001-04-15       Impact factor: 7.396

6.  Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.

Authors:  Andy C Rawstron; Martin R Yuille; Julie Fuller; Matthew Cullen; Ben Kennedy; Stephen J Richards; Andrew S Jack; Estella Matutes; Daniel Catovsky; Peter Hillmen; Richard S Houlston
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

7.  Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.

Authors:  Irene M Ghobrial; Nancy D Bone; Mary J Stenson; Anne Novak; Karen E Hedin; Neil E Kay; Stephen M Ansell
Journal:  Mayo Clin Proc       Date:  2004-03       Impact factor: 7.616

8.  A genome scan of 18 families with chronic lymphocytic leukaemia.

Authors:  Lynn R Goldin; Naoko Ishibe; Maria Sgambati; Gerald E Marti; Laura Fontaine; Maxwell P Lee; Jenny M Kelley; Titia Scherpbier; Kenneth H Buetow; Neil E Caporaso
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

Review 9.  Chronic lymphocytic leukemia: revelations from the B-cell receptor.

Authors:  Freda K Stevenson; Federico Caligaris-Cappio
Journal:  Blood       Date:  2004-02-12       Impact factor: 22.113

10.  Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.

Authors:  Lynn R Goldin; Ruth M Pfeiffer; Xinjun Li; Kari Hemminki
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

View more
  31 in total

1.  Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas.

Authors:  Lynn R Goldin; Ola Landgren; Gerald E Marti; Neil E Caporaso
Journal:  European J Clin Med Oncol       Date:  2010-02

Review 2.  Familial predisposition and genetic risk factors for lymphoma.

Authors:  James R Cerhan; Susan L Slager
Journal:  Blood       Date:  2015-09-24       Impact factor: 22.113

3.  Genetic susceptibility variants for chronic lymphocytic leukemia.

Authors:  Susan L Slager; Lynn R Goldin; Sara S Strom; Mark C Lanasa; Logan G Spector; Laura Rassenti; Jose F Leis; Nicola J Camp; Neil E Kay; Celine M Vachon; Martha Glenn; J Brice Weinberg; Kari G Rabe; Julie M Cunningham; Sara J Achenbach; Curtis A Hanson; Gerald E Marti; Timothy G Call; Neil E Caporaso; James R Cerhan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

4.  Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.

Authors:  Lynn R Goldin; Magnus Björkholm; Sigurdur Y Kristinsson; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

Review 5.  Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Jill Koshiol; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-07       Impact factor: 9.941

Review 6.  Host genetics in follicular lymphoma.

Authors:  James R Cerhan
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-05       Impact factor: 3.020

Review 7.  Familial leukemias.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2015-02

8.  Evolution of a precursor.

Authors:  Neil E Caporaso; Gerald E Marti; Robert F Vogt; Youn K Shim; Dan Middleton; Ola Landgren
Journal:  Cytometry B Clin Cytom       Date:  2010-01       Impact factor: 3.058

Review 9.  Familial chronic lymphocytic leukemia: what does it mean to me?

Authors:  Susan L Slager; Neil E Kay
Journal:  Clin Lymphoma Myeloma       Date:  2009

10.  Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted.

Authors:  Graham M Poage; Brock C Christensen; E Andres Houseman; Michael D McClean; John K Wiencke; Marshall R Posner; John R Clark; Heather H Nelson; Carmen J Marsit; Karl T Kelsey
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.